Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2026, titled "Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS in the U.S., Significantly Expanding its Innovative Portfolio. RYALTRIS is Glenmark s first innovative product introduced into the U.S. market".